Skip to main content

TEMOZOLOMIDE

NDC 16571-821 · Rising Pharma Holdings, Inc.

Generic nametemozolomide
Dosage formCAPSULE
RouteORAL
Active ingredient(s)TEMOZOLOMIDE
Strength250 mg/1
Pharmacologic classAlkylating Activity [MoA], Alkylating Drug [EPC]
Marketing categoryANDA

Packages

16571-821-02 — 20 CAPSULE in 1 BOTTLE (16571-821-02)

16571-821-51 — 5 CAPSULE in 1 BOTTLE (16571-821-51)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0085-1417 — Temozolomide, 0085-1425 — Temozolomide, 0085-1430 — Temozolomide, 0085-1519 — Temozolomide, 0085-3004 — Temozolomide, 16571-816 — temozolomide, 16571-817 — temozolomide, 16571-818 — temozolomide, 16571-819 — temozolomide, 16571-820 — temozolomide, 16729-048 — Temozolomide, 16729-049 — Temozolomide, 16729-050 — Temozolomide, 16729-051 — Temozolomide, 16729-129 — Temozolomide, 16729-130 — Temozolomide, 31722-411 — TEMOZOLOMIDE, 31722-412 — TEMOZOLOMIDE, 31722-413 — TEMOZOLOMIDE, 31722-414 — TEMOZOLOMIDE, +50 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.